WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) gapped up prior to trading on Wednesday after Zacks Research upgraded the stock from a hold rating to a strong-buy rating. The stock had previously closed at $23.16, but opened at $25.72. WuXi AppTec shares last traded at $25.4155, with a volume of 952 shares.
WuXi AppTec Stock Down 0.8%
The firm’s fifty day simple moving average is $25.39 and its 200-day simple moving average is $19.41.
About WuXi AppTec
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}